Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-03

Clinical Trial Update: Steroids and Cross-linking for Ulcer Treatment [Phase 3]

View source ↗

Summary

Phase 3 clinical trial completed evaluating steroids and corneal cross-linking for bacterial keratitis ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corticosteroids (corticosteroids)
  • Riboflavin-mediated corneal cross-linking (Riboflavin-mediated corneal cross-linking)

Snippet

Sponsor: Thomas M. Lietman | Conditions: Keratitis Bacterial | Phase 3 | Status: COMPLETED